Epithelial–Mesenchymal Transition and Stress Adaptations Underlie Yttrium-90 Resistance in Liver Cancer Cell Lines

TARE with 90Y is widely used for liver cancer, yet its molecular determinants of response are poorly understood. Using a diverse panel of liver cancer cell lines, we identify EMT, adhesion, and stress response pathways associated with resistance. These findings highlight candidate biomarkers and molecular vulnerabilities that may guide future therapeutic strategies and patient selection.

Authors

Institutions

Publication Details

Journal
Cancer Research Communications
Published
2025-12-18
DOI
https://doi.org/10.1158/2767-9764.crc-25-0627
Primary Topic
Cancer Cells and Metastasis
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Epithelial–Mesenchymal Transition and Stress Adaptations Underlie Yttrium-90 Resistance in Liver Cancer Cell Lines

Benjamin S. Strnad, Jason D. Weber, A. P. Zheleznyak, J.C. Camacho et al.
Cancer Research Communications
Cancer Cells and Metastasis
article

Epithelial–Mesenchymal Transition and Stress Adaptations Underlie Yttrium-90 Resistance in Liver Cancer Cell Lines

Benjamin S. Strnad, Jason D. Weber, A. P. Zheleznyak, J.C. Camacho, Christine Yoon, Nicholas O. Davidson, Jingxia Liu, Matthew A. Ciorba, Valérie Blanc, Prasanth Thunuguntla, Jessica Silva-Fisher, Daniel L.J. Thorek, Ryan C. Fields, Dhanusha Duraiyan, C. Malone, Shuang Wu
article en

Abstract

TARE with 90Y is widely used for liver cancer, yet its molecular determinants of response are poorly understood. Using a diverse panel of liver cancer cell lines, we identify EMT, adhesion, and stress response pathways associated with resistance. These findings highlight candidate biomarkers and molecular vulnerabilities that may guide future therapeutic strategies and patient selection.

Cancer Research CommunicationsVol. 6(1)
Albert Einstein College of Medicine (US), Washington University in St. Louis (US), Mallinckrodt (United States) (US), Washington University Medical Center (US)
AstraZeneca, Boston Scientific Corporation, Alvin J. Siteman Cancer Center, Eisai, Sirtex Medical, National Institutes of Health, National Cancer Institute, National Institute of Diabetes and Digestive and Kidney Diseases, National Center for Research Resources
Openalex Percentile: Top 43%
Cancer Cells and Metastasis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.